← back to database
Decheng Capital invests in life science and healthcare companies, providing capital and strategic support. It targets early-stage life science startups and growth-stage healthcare firms, backed by a team with complementary expertise. The firm has over $2 billion under management and support from prestigious limited partners. Founded in 2012 and based in Menlo Park, it seeks to create value for investors and entrepreneur partners. Decheng focuses on transformative technologies at the intersection of biology and medicine.
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Min CuiFounder and Managing Director
- Victor Tong Jr.Managing Director
- Peter ColabuonoManaging Director
- Dayton MisfeldtPartner
- Tony TongPartner
- Qiang XuPartner
- Wei XuPartner
- Aaron LiPrincipal
- Shengyang JinVice President
- Michael NotarasVice President
- Joan ChenVice President
- Claire ZhangSenior Associate
- Nick PliamVenture Partner